iBio (IBIO) Stock Heads Up On COVID-19 Vaccine Update

iBio Inc (NYSEAMERICAN: IBIO) is screaming for the top in the market this morning, and for good reason. The company provided an update with regard to their work to develop a vaccine for COVID-19. Here’s what’s going on:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

IBIO Stock Pops On COVID-19 Vaccine Development Update

In the press release, iBio provided an update surrounding one of its proprietary vaccine candidates for the protection of infection from the SARS-CoV-2 virus, the virus that causes COVID-19.

Read more at Alpha Stock News!

Leave a Comment